- ¥5bn
- ¥2bn
- ¥6bn
- 99
- 76
- 35
- 84
Annual income statement for CNS Co, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,434 | 4,578 | 4,841 | 5,419 | 5,989 |
| Cost of Revenue | |||||
| Gross Profit | 711 | 973 | 1,148 | 1,322 | 1,506 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,362 | 4,146 | 4,389 | 4,886 | 5,430 |
| Operating Profit | 72.3 | 432 | 452 | 533 | 559 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 209 | 481 | 483 | 595 | 589 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 143 | 325 | 337 | 409 | 433 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 143 | 325 | 337 | 409 | 433 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 143 | 325 | 337 | 409 | 433 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 66.2 | 116 | 121 | 141 | 149 |
| Dividends per Share | |||||
| Special Dividends per Share |